Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study

• Published in: NPJ breast cancer Vol. 7; no. 1; pp. 90 - 13
• Main Authors: Bartlett, John M. S., Bayani, Jane, Kornaga, Elizabeth, Xu, Keying, Pond, Greg R., Piper, Tammy, Mallon, Elizabeth, Yao, Cindy Q., Boutros, Paul C., Hasenburg, Annette, Dunn, J. A., Markopoulos, Christos, Dirix, Luc, Seynaeve, Caroline, van de Velde, Cornelis J. H., Stein, Robert C., Rea, Daniel
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 08.07.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 692/53/2422; 692/699/67/1347; Biomedical and Life Sciences; Biomedicine; Breast cancer; Cancer Research; Cancer therapies; Cell Biology; Chemotherapy; Clinical trials; Human Genetics; Medical research; Oncology; Pathology; Patients; Survival analysis; Tumors

Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive invasive breast cancer. Recent data from multiple sources suggests that different tests may provide different risk estimates at the individual patient le...